ANTI-CADM-140/MDA5 AUTOANTIBODY TITER PREDICTS DISEASE OUTCOME IN PATIENTS WITH DERMATOMYOSITIS AND RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Takada, Toshinori [1 ]
Asakawa, Katsuaki [1 ]
Sakagami, Takuro [1 ]
Moriyama, Hiroshi [1 ]
Suzuki, Eiichi [2 ]
Narita, Ichiei [1 ]
机构：
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Resp Med, Niigata, Japan
[2] Niigata Univ Med & Dent Hosp, Dept Gen Med, Niigata, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [31] Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis
    Li, Yuhui
    Li, Yimin
    Wu, Jian
    Miao, Miao
    Gao, Xiaojuan
    Cai, Wenxin
    Shao, Miao
    Zhang, Xuewu
    Xu, Yan
    Cong, Lu
    He, Jing
    Sun, Xiaolin
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [32] MDA-5 MEDIATED ILD: DERMATOMYOSITIS TO RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE
    Jarosz, Mark
    Weaver, Michael
    Yerramalla, Yashwanth
    CHEST, 2024, 166 (04) : 3371A - 3372A
  • [33] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [34] Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis
    Kenyon, Sarrinder
    Careless, David
    Navaratnam, Vidya
    Reddy, Taryn
    THORAX, 2023, : 946 - 947
  • [35] Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti-MDA5 antibody titer in two cases
    Awaji, Kentaro
    Asano, Yoshihide
    Fukui, Yuki
    Oka, Tomonori
    Toyama, Tetsuo
    Sato, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 78 - 81
  • [36] Successful rescue treatment of refractory anti-MDA5 autoantibody positive dermatomyositis with rapidly progressive interstitial lung disease using daratumumab
    Chua, C. -G.
    Chai, G. -T.
    Lim, X. -R.
    Manghani, M.
    Leung, B. P. L.
    Koh, L-W
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 460 - 461
  • [37] Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis
    Zhang, Xiao
    Zhou, Shuang
    Wu, Chanyuan
    Li, Mengtao
    Wang, Qian
    Zhao, Yan
    Zeng, Xiaofeng
    RHEUMATOLOGY, 2021, 60 (07) : E227 - E228
  • [38] Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report
    De Backer, Eva
    Gremonprez, Felix
    Brusselle, Guy
    Depuydt, Pieter
    Van Dorpe, Jo
    Van Haverbeke, Carole
    Goeminne, Pieter C.
    Derom, Eric
    ACTA CLINICA BELGICA, 2018, 73 (06) : 413 - 417
  • [39] ANTI-MDA5 DERMATOMYOSITIS: A RARE AND RAPIDLY PROGRESSIVE LIFE-THREATENING INTERSTITIAL LUNG DISEASE
    Marquez, Francisco J.
    Burton, Taylor
    Lau, Christopher
    Iusim, Stephanie
    CHEST, 2023, 164 (04) : 5543A - 5544A
  • [40] PJP as the Index Presentation for Anti-MDA5+Dermatomyositis with Associated Rapidly Progressive Interstitial Lung Disease
    Onofrey, L.
    Harper, A.
    Chung, S.
    Disharoon, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345